Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Hepatitis C infection among pregnant women in British Columbia: reported prevalence and critical appraisal of current prenatal screening methods.

Blasig A, Wagner EC, Pi D, Bigham M, Remple VP, Craib KJ, Doyle P, Dobson S, Yoshida EM, Patrick D, Krajden M, Money DM; BC HCV Vertical Transmission Study Group.

Can J Public Health. 2011 Mar-Apr;102(2):98-102.

PMID:
21608379
2.

The Cedar Project: correlates of attempted suicide among young Aboriginal people who use injection and non-injection drugs in two Canadian cities.

Moniruzzaman A, Pearce ME, Patel SH, Chavoshi N, Teegee M, Adam W, Christian WM, Henderson E, Craib KJ, Schechter MT, Spittal PM; Cedar Project Partnership.

Int J Circumpolar Health. 2009 Jun;68(3):261-73.

PMID:
19705658
3.

Gender differences in HIV and hepatitis C related vulnerabilities among aboriginal young people who use street drugs in two Canadian cities.

Cedar Project Partnership, Mehrabadi A, Paterson K, Pearce M, Patel S, Craib KJ, Moniruzzaman A, Schechter MT, Spittal PM.

Women Health. 2008;48(3):235-60. doi: 10.1080/03630240802463186.

4.

Prevalence and incidence of hepatitis C virus infection among Aboriginal young people who use drugs: results from the Cedar Project.

Craib KJ, Spittal PM, Patel SH, Christian WM, Moniruzzaman A, Pearce ME, Demerais L, Sherlock C, Schechter MT; Cedar Project Partnership.

Open Med. 2009;3(4):e220-7. Epub 2009 Dec 15.

PMID:
21688759
Free PMC Article
5.

The Cedar Project: historical trauma, sexual abuse and HIV risk among young Aboriginal people who use injection and non-injection drugs in two Canadian cities.

Cedar Project Partnership, Pearce ME, Christian WM, Patterson K, Norris K, Moniruzzaman A, Craib KJ, Schechter MT, Spittal PM.

Soc Sci Med. 2008 Jun;66(11):2185-94. doi: 10.1016/j.socscimed.2008.03.034.

6.

The Cedar Project: a comparison of HIV-related vulnerabilities amongst young Aboriginal women surviving drug use and sex work in two Canadian cities.

Mehrabadi A, Craib KJ, Patterson K, Adam W, Moniruzzaman A, Ward-Burkitt B, Schechter MT, Spittal PM; Cedar Project Partnership.

Int J Drug Policy. 2008 Apr;19(2):159-68. Epub 2007 Sep 17.

PMID:
17870461
7.

The Cedar project: prevalence and correlates of HIV infection among young Aboriginal people who use drugs in two Canadian cities.

Spittal PM, Craib KJ, Teegee M, Baylis C, Christian WM, Moniruzzaman AK, Schechter MT; Cedar Project Partnership.

Int J Circumpolar Health. 2007 Jun;66(3):226-40.

PMID:
17655063
8.

Injury rates, predictors of workplace injuries, and results of an intervention program among community health workers.

Craib KJ, Hackett G, Back C, Cvitkovich Y, Yassi A.

Public Health Nurs. 2007 Mar-Apr;24(2):121-31.

PMID:
17319884
9.

HIV and ethnicity in Canada: is the HIV risk-taking behaviour of young foreign-born MSM similar to Canadian born MSM?

George C, Alary M, Hogg RS, Otis J, Remis RS, Mâsse B, Turmel B, Leclerc R, Lavoie R, Vincelette J, Parent R, Chan K, Martindale S, Miller ML, Craib KJ, Schechter MT.

AIDS Care. 2007 Jan;19(1):9-16.

PMID:
17129852
10.

Drastic elevations in mortality among female injection drug users in a Canadian setting.

Spittal PM, Hogg RS, Li K, Craib KJ, Recsky M, Johnston C, Montaner JS, Schechter MT, Wood E.

AIDS Care. 2006 Feb;18(2):101-8.

PMID:
16338767
11.

The cost effectiveness of antiretroviral regimens for the treatment of HIV/AIDS.

Anis AH, Guh D, Hogg RS, Wang XH, Yip B, Craib KJ, O'Shaughnessy MV, Schechter MT, Montaner JS.

Pharmacoeconomics. 2000 Oct;18(4):393-404.

PMID:
15344307
12.

Age, adherence and injection drug use predict virological suppression among men and women enrolled in a population-based antiretroviral drug treatment programme.

O'Connell JM, Braitstein P, Hogg RS, Yip B, Craib KJ, O'Shaughnessy MV, Montaner JS, Burdge DR.

Antivir Ther. 2003 Dec;8(6):569-76.

PMID:
14760890
13.

Surviving the sex trade: a comparison of HIV risk behaviours among street-involved women in two Canadian cities who inject drugs.

Spittal PM, Bruneau J, Craib KJ, Miller C, Lamothe F, Weber AE, Li K, Tyndall MW, O'Shaughnessy MV, Schechter MT.

AIDS Care. 2003 Apr;15(2):187-95.

PMID:
12856340
14.

Health and socioeconomic status differences among antibody hepatitis C positive and negative transfusion recipients, 1986-1990.

Hogg RS, Craib KJ, Pi D, Lee SS, Minuk GY, Shapiro CM, Schechter MT, O'Shaughnessy MV.

Can J Public Health. 2003 Mar-Apr;94(2):130-4.

PMID:
12675170
15.

Determinants of HIV serconversion in an era of increasing HIV infection among young gay and bisexual men.

Weber AE, Craib KJ, Chan K, Martindale S, Miller ML, Cook DA, Schechter MT, Hogg RS.

AIDS. 2003 Mar 28;17(5):774-7. No abstract available.

PMID:
12646809
16.

Length of ICU stay for chronic obstructive pulmonary disease varies among large community hospitals.

Keenan SP, Dodek P, Chan K, Hogg RS, Craib KJ, Anis AH, Spinelli JJ.

Intensive Care Med. 2003 Apr;29(4):590-5. Epub 2003 Mar 15.

PMID:
12640521
17.

Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver.

Craib KJ, Spittal PM, Wood E, Laliberte N, Hogg RS, Li K, Heath K, Tyndall MW, O'Shaughnessy MV, Schechter MT.

CMAJ. 2003 Jan 7;168(1):19-24.

18.

Assessing the impact of an adult day program on hospital utilization by persons living with HIV/AIDS.

Kerr T, Craib KJ, Gataric N, Hogg RS.

J Acquir Immune Defic Syndr. 2002 Sep 1;31(1):117-9. No abstract available.

PMID:
12352159
19.

Intensive care unit admission has minimal impact on long-term mortality.

Keenan SP, Dodek P, Chan K, Hogg RS, Craib KJ, Anis AH, Spinelli JJ.

Crit Care Med. 2002 Mar;30(3):501-7.

PMID:
11990906
20.

Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver.

Spittal PM, Craib KJ, Wood E, Laliberté N, Li K, Tyndall MW, O'Shaughnessy MV, Schechter MT.

CMAJ. 2002 Apr 2;166(7):894-9.

21.

Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients.

Côté HC, Brumme ZL, Craib KJ, Alexander CS, Wynhoven B, Ting L, Wong H, Harris M, Harrigan PR, O'Shaughnessy MV, Montaner JS.

N Engl J Med. 2002 Mar 14;346(11):811-20.

22.

Gay life expectancy revisited.

Hogg RS, Strathdee SA, Craib KJ, O'Shaughnessy MV, Montaner J, Schechter MT.

Int J Epidemiol. 2001 Dec;30(6):1499. No abstract available.

PMID:
11821375
23.

Sex trade involvement and rates of human immunodeficiency virus positivity among young gay and bisexual men.

Weber AE, Craib KJ, Chan K, Martindale S, Miller ML, Schechter MT, Hogg RS.

Int J Epidemiol. 2001 Dec;30(6):1449-54; discussion 1455-6.

PMID:
11821362
24.

Case series assessing the safety of mycophenolate as part of multidrug rescue treatment regimens.

Press N, Kimel G, Harris M, Yip B, Craib KJ, Montaner JS.

HIV Clin Trials. 2002 Jan-Feb;3(1):17-20.

PMID:
11819181
25.

Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy.

Hogg RS, Yip B, Chan KJ, Wood E, Craib KJ, O'Shaughnessy MV, Montaner JS.

JAMA. 2001 Nov 28;286(20):2568-77.

PMID:
11722271
26.

Impact of HIV infection on mortality in a cohort of injection drug users.

Tyndall MW, Craib KJ, Currie S, Li K, O'Shaughnessy MV, Schechter MT.

J Acquir Immune Defic Syndr. 2001 Dec 1;28(4):351-7.

PMID:
11707672
27.

Longitudinal patterns of sexual behavior and condom use in a cohort of HIV-negative gay and bisexual men in Vancouver, British Columbia, Canada, 1995-2000.

Piaseczna MA, Craib KJ, Li K, Chan K, Weber AE, Strathdee SA, Martindale S, Schechter MT, Hogg RS.

J Acquir Immune Defic Syndr. 2001 Oct 1;28(2):187-93.

PMID:
11588514
28.

Risk factors associated with HIV infection among young gay and bisexual men in Canada.

Weber AE, Chan K, George C, Hogg RS, Remis RS, Martindale S, Otis J, Miller ML, Vincelette J, Craib KJ, Mâsse B, Schechter MT, LeClerc R, Lavoie R, Turmel B, Parent R, Alary M.

J Acquir Immune Defic Syndr. 2001 Sep 1;28(1):81-8.

PMID:
11579281
29.

Increasing incidence of HIV infections among young gay and bisexual men in Vancouver.

Hogg RS, Weber AE, Chan K, Martindale S, Cook D, Miller ML, Craib KJ.

AIDS. 2001 Jul 6;15(10):1321-2.

PMID:
11426083
30.

HIV infection and risk behaviours among young gay and bisexual men in Vancouver.

Strathdee SA, Martindale SL, Cornelisse PG, Miller ML, Craib KJ, Schechter MT, O'Shaughnessy MV, Hogg RS.

CMAJ. 2000 Jan 11;162(1):21-5.

31.

Secular trends in the survival of HIV-infected homosexual men in Amsterdam and Vancouver estimated from a death-included CD4-staged Markov model.

Hendriks JC, Craib KJ, Veugelers PJ, van Druten HA, Coutinho RA, Schechter MT, van Griensven GJ.

Int J Epidemiol. 2000 Jun;29(3):565-72.

PMID:
10869332
32.

Comparison of sexual behaviors, unprotected sex, and substance use between two independent cohorts of gay and bisexual men.

Craib KJ, Weber AC, Cornelisse PG, Martindale SL, Miller ML, Schechter MT, Strathdee SA, Schilder A, Hogg RS.

AIDS. 2000 Feb 18;14(3):303-11.

PMID:
10716507
33.

The impact of zidovudine on dementia-free survival in a population of HIV-positive men and women on antiretroviral therapy.

Cornelisse PG, Montessori V, Yip B, Craib KJ, O'Shaughnessy MV, Montaner JS, Hogg RS.

Int J STD AIDS. 2000 Jan;11(1):52-6.

PMID:
10667902
34.

Determinants of short- and long-term outcome in patients with respiratory failure caused by AIDS-related Pneumocystis carinii pneumonia.

Forrest DM, Zala C, Djurdjev O, Singer J, Craib KJ, Lawson L, Russell JA, Montaner JS.

Arch Intern Med. 1999 Apr 12;159(7):741-7.

PMID:
10218755
35.

Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens.

Hogg RS, Yip B, Kully C, Craib KJ, O'Shaughnessy MV, Schechter MT, Montaner JS.

CMAJ. 1999 Mar 9;160(5):659-65.

36.

One world, one hope: the cost of providing antiretroviral therapy to all nations.

Hogg RS, Weber AE, Craib KJ, Anis AH, O'Shaughnessy MV, Schechter MT, Montaner JS.

AIDS. 1998 Nov 12;12(16):2203-9.

PMID:
9833862
37.

Models of survival in HIV infection and their use in the quantification of treatment benefits.

Veugelers PJ, Cornelisse PG, Craib KJ, Marion SA, Hogg RS, Strathdee SA, Montaner JS, O'Shaughnessy MV, Schechter MT.

Am J Epidemiol. 1998 Sep 1;148(5):487-96.

PMID:
9737561
38.

Determinants of sexual risk-taking among young HIV-negative gay and bisexual men.

Strathdee SA, Hogg RS, Martindale SL, Cornelisse PG, Craib KJ, Montaner JS, O'Shaughnessy MV, Schechter MT.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Sep 1;19(1):61-6.

PMID:
9732071
39.

Improved survival among HIV-infected individuals following initiation of antiretroviral therapy.

Hogg RS, Heath KV, Yip B, Craib KJ, O'Shaughnessy MV, Schechter MT, Montaner JS.

JAMA. 1998 Feb 11;279(6):450-4.

PMID:
9466638
40.

Serum levels of human immunodeficiency virus type 1 (HIV-1) RNA after seroconversion: a predictor of long-term mortality in HIV infection.

Craib KJ, Strathdee SA, Hogg RS, Leung B, Montaner JS, O'Shaughnessy MV, Schechter MT.

J Infect Dis. 1997 Sep;176(3):798-800.

PMID:
9291337
41.

Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver.

Patrick DM, Strathdee SA, Archibald CP, Ofner M, Craib KJ, Cornelisse PG, Schechter MT, Rekart ML, O'Shaughnessy MV.

Int J STD AIDS. 1997 Jul;8(7):437-45.

PMID:
9228591
42.

Determinants of complementary therapy use in HIV-infected individuals receiving antiretroviral or anti-opportunistic agents.

Ostrow MJ, Cornelisse PG, Heath KV, Craib KJ, Schechter MT, O'Shaughnessy M, Montaner JS, Hogg RS.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Jun 1;15(2):115-20.

PMID:
9241109
43.

Modelling the impact of HIV disease on mortality in gay and bisexual men.

Hogg RS, Strathdee SA, Craib KJ, O'Shaughnessy MV, Montaner JS, Schechter MT.

Int J Epidemiol. 1997 Jun;26(3):657-61.

PMID:
9222793
44.

Adherence to guidelines for the prevention of HIV-related respiratory diseases.

Montaner JS, Phillips P, Zala C, Craib KJ, O'Shaughnessy MV, Schechter MT.

Eur Respir J. 1996 Nov;9(11):2318-22.

45.

Heterogeneity of physician agreement with recommended therapeutic guidelines for the management of HIV-associated disease.

Montaner JS, Hogg RS, Heath KV, Phillips P, Craib KJ, Schechter MT, O'Shaughnessy MV.

Antivir Ther. 1996 Aug;1(3):157-66.

PMID:
11322249
46.

Long-term non-progression in HIV infection.

Strathdee SA, Craib KJ, Hogg RS, O'Shaughnessy MV, Montaner JS, Schechter MT.

Lancet. 1995 Nov 18;346(8986):1372. No abstract available.

PMID:
7475806
47.

Analysis of nutritional intake in a cohort of homosexual men.

Hogg RS, Zadra JN, Chan-Yan C, Voigt R, Craib KJ, Korosi-Ronco J, Montaner JS, Schechter MT.

J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Jun 1;9(2):162-7.

PMID:
7749793
48.

Rectal gonorrhoea as an independent risk factor for HIV infection in a cohort of homosexual men.

Craib KJ, Meddings DR, Strathdee SA, Hogg RS, Montaner JS, O'Shaughnessy MV, Schechter MT.

Genitourin Med. 1995 Jun;71(3):150-4.

49.

Use of the Markov model to estimate the waiting times in a modified WHO staging system for HIV infection.

Schechter MT, Le N, Craib KJ, Le TN, O'Shaughnessy MV, Montaner JS.

J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Apr 15;8(5):474-9.

PMID:
7697444
50.

Lower socioeconomic status and shorter survival following HIV infection.

Hogg RS, Strathdee SA, Craib KJ, O'Shaughnessy MV, Montaner JS, Schechter MT.

Lancet. 1994 Oct 22;344(8930):1120-4.

PMID:
7934494

Supplemental Content

Loading ...
Support Center